Monitor the filing and effectiveness of the resale registration statement over the next 30-90 days; any delays triggering liquidated damages would signal execution risk but are not material to the business outlook.
Price Chart
Executive Summary
First Tracks Biotherapeutics closed a private placement of 6,106,870 shares of common stock on October 19, 2026, and entered into a Registration Rights Agreement with the investors. The agreement requires the company to file a resale registration statement with the SEC within 30 days and includes liquidated damages provisions for delays. This is a routine post-closing administrative filing with no new financial details or business updates.
Key Facts
- Private placement of 6,106,870 shares closed on October 19, 2026.
- Registration Rights Agreement requires filing a resale registration statement within 30 days of closing.
- Liquidated damages of 1.0% per 30-day period apply for registration delays, capped at 5.0% of purchase price.
- Company must use reasonable best efforts to have the registration statement declared effective within 60 days of filing (or 5 business days if no SEC review).
Financial Impact
No financial terms of the private placement (price per share, gross proceeds) were disclosed in this filing.
Risk Factors
- Potential overhang from the 6.1M shares being registered for resale by investors.
- Liquidated damages exposure if registration deadlines are missed.
Investment Themes
Documents Analyzed
This report is based on 5 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (Primary) | 0001193125-26-426666 |
| Document: trax-20261019.htm | 0001193125-26-426666 |
| Document: 0001193125-26-426666-index-headers.html | 0001193125-26-426666 |
| Document: 0001193125-26-426666-index.html | 0001193125-26-426666 |
| Document: 0001193125-26-426666.txt | 0001193125-26-426666 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 26, 2026 today | S-1 | $43.80 | awaiting T+1 | — | $44.05 (+0.57%) |
Oct 20, 2026 5d ago | 8-K | $42.77 $43.14 | ▲ +0.87% | ▲ +2.05% | $44.05 (+2.99%) |
Oct 15, 2026 10d ago | 8-K | $34.46 $36.28 | ▼ −5.28% | ▼ −4.86% | $44.05 (−27.83%) |
Oct 15, 2026 11d ago | Press Release | $36.04 $34.46 | ▲ +4.38% | ▲ +3.28% | $44.05 (−22.23%) |
Oct 13, 2026 13d ago | 8-K | $31.68 $34.13 | ▲ +7.73% | ▲ +8.81% | $44.05 (+39.05%) |
Aug 12, 2026 10w ago | 8-K | $44.03 $44.04 | ▲ +0.02% | ▲ +0.22% | $44.05 (+0.05%) |
Aug 12, 2026 10w ago | Press Release | $44.03 $44.04 | ▲ +0.02% | ▲ +0.22% | $44.05 (+0.05%) |
Aug 7, 2026 11w ago | 3/A | $47.92 $46.75 | ▼ −2.44% | ▼ −2.12% | $44.05 (−8.08%) |
Jun 22, 2026 17w ago | 8-K | $17.78 $16.69 | ▼ −6.13% | ▼ −6.08% | $44.05 (+147.75%) |
May 14, 2026 23w ago | 8-K | $16.90 $17.79 | ▲ +5.27% | ▲ +5.33% | $44.05 (+160.65%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers